Corticosteroid Use in Early Pregnancy: Indications, Risks, and Monitoring

Prednisone/Prednisolone in the First Trimester

Corticosteroids cross the placenta but are largely inactivated by placental 11β-HSD2. Low-dose prednisone (<10–20 mg/day) is generally considered compatible with pregnancy when benefits outweigh risks.

Common Indications

  1. Autoimmune Disease Flare: SLE, antiphospholipid syndrome, autoimmune thyroiditis – maintain remission.
  2. Adrenal Insufficiency: Physiologic replacement (hydrocortisone preferred; prednisone if needed).
  3. Severe Allergic/Anaphylactic Reactions: Short-course rescue.
  4. Hyperemesis Gravidarum: Refractory cases; short-term.
  5. Asthma/IBD Exacerbation: When uncontrolled poses greater fetal risk than medication.

Potential Risks (Dose/Duration Dependent)

  • Oral clefts (slight increase with first-trimester systemic use; absolute risk remains low).
  • Preterm birth, low birth weight (confounded by underlying disease).
  • Maternal: gestational diabetes, hypertension, infection susceptibility.

Monitoring

  • Maternal glucose, BP, weight.
  • Fetal anatomy scan (18–22 weeks).
  • Lowest effective dose; taper when possible.

Key Principle

Shared decision-making with rheumatology/OB; untreated active disease often carries higher fetal risk than low-dose steroids.

Pregnancy & Health - Related Articles